SPA
PBH icon

Sherbrooke Park Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Sherbrooke Park Advisers’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,298
Closed -$206K – 448
2025
Q3 		$206K Buy
+3,298
New +$230K 0.1% 377
2024
Q4 		– Sell
-3,082
Closed -$222K – 1062
2024
Q3 		$222K Buy
+3,082
New +$218K 0.05% 714

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sherbrooke Park Advisers's PBH Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 3,298 shares — an estimated $206K sold.

Sherbrooke Park Advisers first reported a position in PBH in Q3 2024 and held it in 2 quarters. The position peaked at $222K in Q3 2024. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 3,298 Prestige Consumer Healthcare shares in Q4 2025, an estimated $206K.
  • Sherbrooke Park Advisers first reported a position in Prestige Consumer Healthcare in Q3 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Prestige Consumer Healthcare position peaked at $222K in Q3 2024.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.